Avara Pharmaceutical Services is a contract manufacturing organization (CMO) that utilizes their institutional expertise, lean management structure, proven track record of regulatory success, and extensive global reach to provide a tailored and flexible manufacturing and packaging experience. Avara—our exclusive OSD sponsor—offers a client-centered approach that leverages an extensive regulatory track record to implement industry best practices across all sites. This enables them to efficiently support various market and supply chain segments with oral solid dose and sterile fill-finish drug product, as well as integrated packaging capabilities.
How is Avara Pharmaceutical Services contributing to the future of healthcare?
Avara’s core services are the manufacturing and supply of oral solid dose (OSD) and sterile injectable products, as well as integrated packaging services. The company supports the future of healthcare by investing in innovations that extend or complement these core competencies. Recently, Avara has been instrumental in the manufacturing of supplies needed for the treatment of COVID-19, such as sterile drugs that support intensive care patients. Additionally, Avara’s OSD service line is initiating manufacture of a variety of potential COVID-19 therapies.